CSIMarket Company Name, Ticker, Industry, else..
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Inc. COP Y/Y Annual
Purple Biotech Ltd   (PPBT)
Other Ticker:  
 
 

Purple Biotech Ltd 's Yearly Income from Continued Operations Growth 5 Years
 

Select the Comparisons : Select the Ratio:



PPBT Annual Income from Cont. Operations Growth

 2022
2021
2020
2019
2018
Y / Y Annual Income from Cont. Operations Change 17.83 % -34.22 % 376.4 % 5.82 % -
Annual Income from Cont. Operations (in millions $) $21.76 $18.47 $28.07 $5.89 $5.57

PPBT Company Profile >> Back to PPBT Fundamentals at a Glance >> Back to PPBT Growth Comparisons

Annual Income from Cont. Operations Growth Comment
Purple Biotech Ltd 's Annual Income from Cont. Operations for the fiscal year ended 2022, grew by 17.83% to $21.76 millions, from $18.47 millions achieved a year ago. Purple Biotech Ltd 's growrh rate for Income from Continued Operations improved from -34.22 % decline in the fiscal year 2021.

Purple Biotech Ltd Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2022 Annual Income from Cont. Operations within Healthcare SectorY/Y Income from Continued Operations Growth %2022 Annual Income from Cont. Operations
Sinovac Biotech Ltd -99.39 %$ 88.131  millions
Fulgent Genetics Inc -71.97 %$ 141.923  millions
Halozyme Therapeutics Inc -49.81 %$ 202.129  millions
Community Health Systems Inc -51.36 %$ 179.000  millions
Uniqure N v